Related Experiment Video
Updated: Dec 31, 2025

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis
Alexandre R Marra1,2,3, Eli N Perencevich1,3, Richard E Nelson4,5
1Carver College of Medicine, Department of Internal Medicine, University of Iowa, Iowa City.
Clostridium difficile infection (CDI) affects 8.3 per 10,000 patient-days in the US. CDI significantly increases hospital length of stay (LOS), ranging from 3 to 21.6 days, highlighting a substantial healthcare burden.
Area of Science:
- Infectious Diseases
- Epidemiology
- Health Services Research
Background:
- Clostridium difficile infection (CDI) poses a significant challenge to healthcare systems.
- Understanding the incidence and outcomes of CDI is crucial for developing effective interventions.
Purpose of the Study:
- To systematically review and meta-analyze the incidence of CDI in the United States.
- To quantify the association between CDI and hospital length of stay (LOS).
Main Methods:
- A systematic literature search was conducted across major databases for US-based studies from 2000-2019.
- Data from multicenter studies on CDI incidence and propensity score-matched studies on LOS were pooled.
- Random-effects models were employed for meta-analysis, with heterogeneity assessed using I2 statistics.
Main Results:
- The pooled incidence of hospital-onset CDI was 8.3 cases per 10,000 patient-days.
- CDI was associated with an increased mean LOS, ranging from 3.0 to 21.6 days in propensity score-matched studies.
- Significant heterogeneity was observed across studies.
Conclusions:
- Pooled data indicate a substantial healthcare burden associated with CDI in the United States.
- Further high-quality research is recommended to refine estimates and guide prevention and treatment strategies.
- These findings underscore the importance of continued investment in CDI control measures.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

